Multicenter screening for ADHD among school-age pediatric patients with type 1 diabetes – study protocol.
Saved in:
| Title: | Multicenter screening for ADHD among school-age pediatric patients with type 1 diabetes – study protocol. |
|---|---|
| Authors: | Kuśmierczyk-Kozieł, Hanna (AUTHOR), Michalak, Arkadiusz (AUTHOR), Chrzanowski, Jędrzej (AUTHOR), Błaziak, Katarzyna (AUTHOR), Mianowska, Beata (AUTHOR), Szadkowska, Agnieszka (AUTHOR), Chobot, Agata (AUTHOR), Jarosz-Chobot, Przemysława (AUTHOR), Myśliwiec, Małgorzata (AUTHOR), Makowska, Iwona (AUTHOR), Kalenik, Anna (AUTHOR), Rzeszutek, Marcin (AUTHOR), Zamarlik, Monika (AUTHOR), Rusak, Ewa (AUTHOR), Kaczmarek, Anna (AUTHOR), Nowak, Aleksandra (AUTHOR), Połaniecka, Magdalena (AUTHOR), Musiał-Paździor, Malwina (AUTHOR), Szmigiel, Klaudia (AUTHOR), Sobota-Krawczyk, Anna (AUTHOR) |
| Source: | Nordic Journal of Psychiatry. Feb2025, Vol. 79 Issue 2, p136-145. 10p. |
| Subjects: | Type 1 diabetes, Attention-deficit hyperactivity disorder, Diabetes in children, Child patients, Polish people |
| Abstract: | Purpose: Attention-deficit hyperactivity disorder (ADHD) is a common neurodevelopmental condition that affects approximately 5% of the pediatric population, with increased prevalence among those with type 1 diabetes (T1D). Reports suggest that unrecognized and untreated ADHD impairs T1D control and that ADHD may be underdiagnosed in the Polish population. The International Society for Pediatric and Adolescent Diabetes recommends neurodevelopmental assessments in children with T1D, but specific guidelines on procedures and implementation are lacking. Therefore, we designed a systemic screening protocol aimed at assessing the prevalence of ADHD among Polish children with T1D that could be utilized in clinical practice. Materials and methods: The protocol for the study was approved by the Bioethical Committee at the Medical University of Lodz (RNN/280/21/KE). Participation is offered to all children aged 8–16 y.o. with T1D duration ≥1 year and without significant comorbidities (epilepsy, intellectual disability). The protocol includes a first-line procedure using the short version of the Conners 3 questionnaire and on-site structured consultation with a psychologist for those with increased risk of ADHD (utilizing detailed Conners 3 and MINI-Kid questionnaires), followed by a video consultation with a psychiatrist. Results: The screening was initiated between January and May 2023 and is ongoing in four Polish reference pediatric centers. These centers provide diabetes care to approximately 2,500 youth with T1D. Over 36 months, our goal is to assist in diagnosing ADHD in approximately 190 children. Conclusions: Comorbidity of ADHD and T1D remains an unrecognized challenge for pediatric psychiatric and diabetes care, and there is a need for effective diagnostic protocols. [ABSTRACT FROM AUTHOR] |
| Copyright of Nordic Journal of Psychiatry is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
